Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Sarcoma × tozuleristide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Sarcoma 1 Melanoma 1 Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Doxorubicin 23 Cyclophosphamide 23 Gemcitabine 14 Radiotherapy 11 Filgrastim 11 pazopanib 10 Cisplatin 9 pembrolizumab 8 Docetaxel 8 Radiation 7 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Busulfan 7 fludarabine 6 Trabectedin 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Melphalan 6 Ipilimumab 6 Etoposide 6 Carboplatin 6 Bevacizumab 6 selinexor 5 olaratumab 4 aflibercept 4 Topotecan 4 Thiotepa 4 Temozolomide 4 Nivolumab 4 Methotrexate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02464332 2016-05-26

Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery

Blaze Bioscience Inc.

Phase 1 Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡